Kingchem (Liaoning) Life Science Co., Ltd. (SZSE: 301509)
Health Care · Pharmaceuticals · CN
CN¥33.80
+7.85% today · -19.0% 1Y
Kingchem (Liaoning) Life Science Co., Ltd. (SZSE: 301509) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $603.61M.
Over the last twelve months the share price has lost 19.0%, trading between 25.65 and 48.60.
Tweenvest scores Kingchem (Liaoning) Life Science Co., Ltd. across four factors: quality 68/100, value 42/100, growth 78/100, dividend 45/100. Its strongest factor is growth.
301509 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $603.61M
- Revenue (TTM)
- $88.60M
- P/E
- 54.69
- EPS
- 0.62
- Dividend yield
- 2.66%
- Beta (5Y)
- 0.31
- 52-week high
- CN¥48.60
- 52-week low
- CN¥25.65
- Avg volume (3M)
- —
- Shares outstanding
- 120.45M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.35 | +0.16% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.